China News Service, Lianyungang, November 9th (Reporter Gu Hua) From November 8th to 9th, the 8th Lianyungang Pharmaceutical Technology Conference with the theme of "Intelligent Gathering of China Pharmaceutical Port: AI Driven Pharmaceutical Innovation and Global Cooperation" was held in Lianyungang Economic Development Zone. Academicians and experts, scholar representatives and business leaders from the pharmaceutical field gathered at the "China Pharmaceutical Port" to discuss artificial intelligence empowering pharmaceutical innovation and industrial openness and cooperation.
The biopharmaceutical industry is a characteristic leading industry that Lianyungang focuses on cultivating. In recent years, Lianyungang has given full play to the promotion role of the Medical Technology Conference and relied on the platform carrier of "China Pharmaceutical Port" to promote pharmaceutical technology innovation, high-end resource gathering, and industry exchanges and cooperation. The biopharmaceutical industry has become an important and highly recognizable and competitive pole in the national pharmaceutical field.
Meeting site. Photo courtesy of Lianyungang Economic Development Zone
This conference adopts a "1+3" format, that is, 1 main forum + 3 sub-forums, focusing on AI-driven pharmaceutical innovation and global cooperation, pharmaceutical internationalization, AI+ pharmaceutical industry innovation, biopharmaceutical industry chain innovation and domestic substitution, etc. The conference aims to gather high-end innovation resources in the pharmaceutical field, promote the deep integration of AI technology and the pharmaceutical industry, deepen international pharmaceutical innovation cooperation, help the pharmaceutical industry chain strengthen and extend the chain, and empower the high-quality development of the pharmaceutical industry.
"Currently, the deep integration of artificial intelligence and biomedicine is becoming an important driving force for innovation and change in the industry." Xing Zhengjun, Secretary of the Lianyungang Municipal Party Committee, said that he hopes that all guests will have in-depth exchanges and discussions, contribute insights, and deploy more cutting-edge technologies, innovative results, and high-quality projects in Lianyungang to help the digital and intelligent transformation of Lianyungang's biopharmaceutical industry and jointly polish the "Chinese Pharmaceutical Port" brand.
At the opening ceremony, the "Artificial Intelligence + Medicine" public service platform was officially launched, Jiangsu New Medicine International Talent Innovation Port and the Pharmaceutical Artificial Intelligence Industry Research Institute were unveiled, and a series of platform carriers were launched, marking a key step for the "Chinese Medicine Port" in gathering global pharmaceutical innovation resources, building an "AI + medicine" industrial ecology, and promoting the transformation of results and domestic substitution, injecting new momentum into strengthening industry chain collaboration and enhancing international innovation capabilities.
At the main forum, experts, scholars and business representatives made special reports on topics such as drug review policy, intelligent research and development of traditional Chinese medicine with functional substances as the core, domestic innovative medical devices breaking through after obtaining certification, localization of transdermal delivery patches, pharmaceutical digital transformation, and efficient CMC development of biopharmaceuticals overseas, providing useful reference for promoting the transformation and upgrading of the pharmaceutical industry.
During the conference, three sub-forums were held: a special training session for pharmaceutical companies going overseas during the “15th Five-Year Plan” period, a seminar on artificial intelligence + pharmaceutical industry innovation, and biopharmaceutical industry chain innovation and domestic substitution, and negotiation and docking activities were held.
As the core site for the construction of the "Chinese Pharmaceutical Port", Lianyungang Economic and Technological Development Zone insists on empowering research and development with AI, connecting the world with openness, and driving the industry with innovation, accelerating the transformation of platform advantages into project advantages, technological advantages and cluster advantages, and promoting the pharmaceutical industry to move towards high-end, intelligent, and internationalization. (over)
